July 24, 2025
Video
In this on-demand webinar series, Dr. Igor Makhlin discusses personalized treatment options for ER-positive, HER2-negative metastatic breast cancer, including the role of ESR1 mutation testing and targeted therapies like Orserdu.
Anemia Management in Myelofibrosis: Survival and Quality of Life
Simple Ways for Patients With Cancer to Start Exercising
Finding Credible Voices in the Lynch Syndrome Community
Understanding Your Stage 2 Lymphoma Diagnosis